BioWorld Archives

20 Aug, 2020

Alzheon receives $47M NIH grant funding its phase III Alzheimer’s study

alzheon2020-08-21T21:04:15-04:00August 20th, 2020|Tags: BioWorld|

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

This website uses cookies and third-party services. By clicking "ACCEPT", you confirm that you have read and are agreeing to our privacy policy and the use of ALL cookies. ACCEPT